Literature DB >> 20077085

Multiplex lysosomal enzyme activity assay on dried blood spots using tandem mass spectrometry.

X Kate Zhang1, Carole S Elbin, Frantisek Turecek, Ronald Scott, Wei-Lien Chuang, Joan M Keutzer, Michael Gelb.   

Abstract

Deficiencies in any of the 50 degradative enzymes found in lysosomes results in the accumulation of undegraded material and subsequently cellular dysfunction. Early identification of deficiencies before irreversible organ and tissue damages occur leads to better clinical outcomes. In the method which follows, lysosomal alpha-glucosidase, alpha-galactosidase, beta-glucocerebrosidase, acid sphingomyelinase, and galactocerebrosidase are extracted from dried blood spots and incubated individually with an enzyme-specific cocktail containing the corresponding substrate and internal standard. Each enzyme cocktail is prepared using commercially available mixture of substrate and internal standard at the predetermined optimized molar ratio. After incubation, the enzymatic reactions are quenched using an ethyl acetate/methanol solution and all five enzyme solutions are combined. The mixtures of the reaction products are prepared using liquid-liquid and solid-phase extractions and quantified simultaneously using selected ion monitoring on LC-MS-MS system.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20077085      PMCID: PMC3442156          DOI: 10.1007/978-1-60761-459-3_32

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  10 in total

1.  Direct multiplex assay of lysosomal enzymes in dried blood spots for newborn screening.

Authors:  Yijun Li; C Ronald Scott; Nestor A Chamoles; Ahmad Ghavami; B Mario Pinto; Frantisek Turecek; Michael H Gelb
Journal:  Clin Chem       Date:  2004-08-03       Impact factor: 8.327

2.  Tandem mass spectrometry for the direct assay of enzymes in dried blood spots: application to newborn screening for Krabbe disease.

Authors:  Yijun Li; Knut Brockmann; Frantisek Turecek; C Ronald Scott; Michael H Gelb
Journal:  Clin Chem       Date:  2004-03       Impact factor: 8.327

Review 3.  Treatment of lysosomal storage disorders : progress with enzyme replacement therapy.

Authors:  Marianne Rohrbach; Joe T R Clarke
Journal:  Drugs       Date:  2007       Impact factor: 9.546

Review 4.  The mucopolysaccharidoses: a success of molecular medicine.

Authors:  Lorne A Clarke
Journal:  Expert Rev Mol Med       Date:  2008-01-18       Impact factor: 5.600

5.  Newborn screening for Pompe disease by measuring acid alpha-glucosidase activity using tandem mass spectrometry.

Authors:  Angéla Dajnoki; Adolf Mühl; György Fekete; Joan Keutzer; Joe Orsini; Victor Dejesus; X Kate Zhang; Olaf A Bodamer
Journal:  Clin Chem       Date:  2008-08-14       Impact factor: 8.327

6.  Development and evaluation of quality control dried blood spot materials in newborn screening for lysosomal storage disorders.

Authors:  Victor R De Jesus; X Kate Zhang; Joan Keutzer; Olaf A Bodamer; Adolf Mühl; Joseph J Orsini; Michele Caggana; Robert F Vogt; W Harry Hannon
Journal:  Clin Chem       Date:  2008-11-06       Impact factor: 8.327

7.  Tandem mass spectrometry for the direct assay of lysosomal enzymes in dried blood spots: application to screening newborns for mucopolysaccharidosis I.

Authors:  Sophie Blanchard; Martin Sadilek; C Ronald Scott; Frantisek Turecek; Michael H Gelb
Journal:  Clin Chem       Date:  2008-12       Impact factor: 8.327

8.  Early detection of Pompe disease by newborn screening is feasible: results from the Taiwan screening program.

Authors:  Yin-Hsiu Chien; Shu-Chuan Chiang; Xiaokui Kate Zhang; Joan Keutzer; Ni-Chung Lee; Ai-Chu Huang; Chun-An Chen; Mei-Hwan Wu; Pei-Hsin Huang; Fu-Jen Tsai; Yuan-Tsong Chen; Wuh-Liang Hwu
Journal:  Pediatrics       Date:  2008-06-02       Impact factor: 7.124

9.  Multiplex enzyme assay screening of dried blood spots for lysosomal storage disorders by using tandem mass spectrometry.

Authors:  X Kate Zhang; Carole S Elbin; Wei-Lien Chuang; Samantha K Cooper; Carla A Marashio; Christa Beauregard; Joan M Keutzer
Journal:  Clin Chem       Date:  2008-08-21       Impact factor: 8.327

Review 10.  Lysosomal storage disorders: emerging therapeutic options require early diagnosis.

Authors:  Peter J Meikle; John J Hopwood
Journal:  Eur J Pediatr       Date:  2003-11-11       Impact factor: 3.183

  10 in total
  11 in total

1.  Toward a consensus in the laboratory diagnostics of Fabry disease - recommendations of a European expert group.

Authors:  Andreas Gal; Derralynn A Hughes; Bryan Winchester
Journal:  J Inherit Metab Dis       Date:  2011-01-13       Impact factor: 4.982

2.  Multiplex Tandem Mass Spectrometry Enzymatic Activity Assay for Newborn Screening of the Mucopolysaccharidoses and Type 2 Neuronal Ceroid Lipofuscinosis.

Authors:  Yang Liu; Fan Yi; Arun Babu Kumar; Naveen Kumar Chennamaneni; Xinying Hong; C Ronald Scott; Michael H Gelb; Frantisek Turecek
Journal:  Clin Chem       Date:  2017-04-20       Impact factor: 8.327

Review 3.  Newborn screening for lysosomal storage diseases.

Authors:  Michael H Gelb; C Ronald Scott; Frantisek Turecek
Journal:  Clin Chem       Date:  2014-12-04       Impact factor: 8.327

4.  Tandem mass spectrometry assay of β-glucocerebrosidase activity in dried blood spots eliminates false positives detected in fluorescence assay.

Authors:  Pavlina Wolf; Roy N Alcalay; Christopher Liong; Emmaline Cullen; Michael W Pauciulo; William C Nichols; Ziv Gan-Or; Wendy K Chung; Tina Faulkner; Christopher Bentis; Robert J Pomponio; Xiwen Ma; X Kate Zhang; Joan M Keutzer; Petra Oliva
Journal:  Mol Genet Metab       Date:  2017-10-23       Impact factor: 4.797

5.  Krabbe disease in adults: phenotypic and genotypic update from a series of 11 cases and a review.

Authors:  Rabab Debs; Roseline Froissart; Patrick Aubourg; Caroline Papeix; Claire Douillard; Bertrand Degos; Bertrand Fontaine; Bertrand Audoin; Arnaud Lacour; Gérard Said; Marie T Vanier; Frédéric Sedel
Journal:  J Inherit Metab Dis       Date:  2012-11-30       Impact factor: 4.982

6.  Pilot study of newborn screening for six lysosomal storage diseases using Tandem Mass Spectrometry.

Authors:  Susan Elliott; Norman Buroker; Jason J Cournoyer; Anna M Potier; Joseph D Trometer; Carole Elbin; Mack J Schermer; Jaana Kantola; Aaron Boyce; Frantisek Turecek; Michael H Gelb; C Ronald Scott
Journal:  Mol Genet Metab       Date:  2016-05-20       Impact factor: 4.797

7.  Decreased Activity of Blood Acid Sphingomyelinase in the Course of Multiple Myeloma.

Authors:  Marzena Wątek; Ewelina Piktel; Joanna Barankiewicz; Ewa Sierlecka; Sylwia Kościołek-Zgódka; Anna Chabowska; Łukasz Suprewicz; Przemysław Wolak; Bonita Durnaś; Robert Bucki; Ewa Lech-Marańda
Journal:  Int J Mol Sci       Date:  2019-11-30       Impact factor: 5.923

8.  Newborn screening for Morquio disease and other lysosomal storage diseases: results from the 8-plex assay for 70,000 newborns.

Authors:  Yin-Hsiu Chien; Ni-Chung Lee; Pin-Wen Chen; Hui-Ying Yeh; Michael H Gelb; Pao-Chin Chiu; Shao-Yin Chu; Chen-Hao Lee; An-Ru Lee; Wuh-Liang Hwu
Journal:  Orphanet J Rare Dis       Date:  2020-02-03       Impact factor: 4.123

9.  Improved reagents for newborn screening of mucopolysaccharidosis types I, II, and VI by tandem mass spectrometry.

Authors:  Naveen Kumar Chennamaneni; Arun Babu Kumar; Mariana Barcenas; Zdeněk Spáčil; C Ronald Scott; František Tureček; Michael H Gelb
Journal:  Anal Chem       Date:  2014-04-21       Impact factor: 6.986

10.  Glucocerebrosidase Activity is Reduced in Cryopreserved Parkinson's Disease Patient Monocytes and Inversely Correlates with Motor Severity.

Authors:  Laura P Hughes; Marilia M M Pereira; Deborah A Hammond; John B Kwok; Glenda M Halliday; Simon J G Lewis; Nicolas Dzamko
Journal:  J Parkinsons Dis       Date:  2021       Impact factor: 5.568

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.